373
On 3 July 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 381. The active ingredient is human monoclonal antibody against Pseudomonas aeruginosa serotype O11 for treatment of pneumonia caused by serotype O11 Pseudomonas aeruginosa.